David Toung
Stock Analyst at Argus Research
(4.15)
# 431
Out of 5,182 analysts
133
Total ratings
63.46%
Success rate
9.51%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Upgrades: Buy | $400 | $354.92 | +12.70% | 9 | Apr 22, 2026 | |
| IART Integra LifeSciences Holdings | Downgrades: Hold | n/a | $10.57 | - | 3 | Apr 15, 2026 | |
| MDT Medtronic | Maintains: Buy | $125 → $115 | $83.32 | +38.02% | 8 | Apr 6, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $230 → $180 | $152.14 | +18.31% | 1 | Mar 23, 2026 | |
| PFE Pfizer | Upgrades: Buy | $35 | $27.00 | +29.63% | 2 | Mar 2, 2026 | |
| HCA HCA Healthcare | Maintains: Buy | $530 → $560 | $432.46 | +29.49% | 3 | Feb 6, 2026 | |
| TECH Bio-Techne | Maintains: Buy | $65 → $68 | $54.19 | +25.50% | 4 | Nov 20, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $580 → $610 | $469.71 | +29.87% | 8 | Oct 29, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $215.23 | +31.02% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $344.76 | - | 4 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $61.79 | -15.84% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $198.71 | - | 6 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $199.85 | -37.45% | 9 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $169.80 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $344.55 | -1.32% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $828.11 | -19.09% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $91.26 | +64.37% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $883.96 | -4.97% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $68.83 | +59.81% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $263.80 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $327.51 | -5.35% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $482.22 | -33.64% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $91.13 | +48.14% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $130.40 | -42.48% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $58.71 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $111.90 | -1.70% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.75 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $189.75 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $145.47 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $227.50 | -31.87% | 4 | Mar 27, 2020 |
UnitedHealth Group
Apr 22, 2026
Upgrades: Buy
Price Target: $400
Current: $354.92
Upside: +12.70%
Integra LifeSciences Holdings
Apr 15, 2026
Downgrades: Hold
Price Target: n/a
Current: $10.57
Upside: -
Medtronic
Apr 6, 2026
Maintains: Buy
Price Target: $125 → $115
Current: $83.32
Upside: +38.02%
Becton, Dickinson and Company
Mar 23, 2026
Maintains: Buy
Price Target: $230 → $180
Current: $152.14
Upside: +18.31%
Pfizer
Mar 2, 2026
Upgrades: Buy
Price Target: $35
Current: $27.00
Upside: +29.63%
HCA Healthcare
Feb 6, 2026
Maintains: Buy
Price Target: $530 → $560
Current: $432.46
Upside: +29.49%
Bio-Techne
Nov 20, 2025
Maintains: Buy
Price Target: $65 → $68
Current: $54.19
Upside: +25.50%
Thermo Fisher Scientific
Oct 29, 2025
Maintains: Buy
Price Target: $580 → $610
Current: $469.71
Upside: +29.87%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $215.23
Upside: +31.02%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $344.76
Upside: -
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $61.79
Upside: -15.84%
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $198.71
Upside: -
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $199.85
Upside: -37.45%
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $169.80
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $344.55
Upside: -1.32%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $828.11
Upside: -19.09%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $91.26
Upside: +64.37%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $883.96
Upside: -4.97%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $68.83
Upside: +59.81%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $263.80
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $327.51
Upside: -5.35%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $482.22
Upside: -33.64%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $91.13
Upside: +48.14%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $130.40
Upside: -42.48%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $58.71
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $111.90
Upside: -1.70%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $5.75
Upside: -
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $189.75
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $145.47
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $227.50
Upside: -31.87%